Gene expression in dopamine and GABA systems in an animal model of schizophrenia: Effects of antipsychotic drugs

European Journal of Neuroscience

Volumn 18, Issue 2, 2003, Pages 391-402

  Lipska, Barbara K ^a   Lerman, Daniel N ^a   Khaing, Zin Z ^a   Weickert, Cynthia Shannon ^a   Weinberger, Daniel R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Clozapine; Dopamine receptors; GAD 67; Haloperidol; Neurotensin; Prodynorphin; Proenkephalin

Indexed keywords

CLOZAPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; GLUTAMATE DECARBOXYLASE; HALOPERIDOL; MESSENGER RNA; NEUROLEPTIC AGENT; NEUROTENSIN; PRODYNORPHIN; PROENKEPHALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRUG DOSE REGIMEN; FEMALE; GABAERGIC SYSTEM; GENE EXPRESSION; HIPPOCAMPUS; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCHIZOPHRENIA;

ANIMALS; ANIMALS, NEWBORN; ANTIPSYCHOTIC AGENTS; BRAIN; CLOZAPINE; DOPAMINE; ENKEPHALINS; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLUTAMATE DECARBOXYLASE; HALOPERIDOL; IBOTENIC ACID; IN SITU HYBRIDIZATION; ISOENZYMES; MALE; MODELS, ANIMAL; NEUROTENSIN; PROTEIN PRECURSORS; RATS; RECEPTORS, DOPAMINE; RNA, MESSENGER; SCHIZOPHRENIA; TIME FACTORS;

EID: 0041733102     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2003.02738.x     Document Type: Article

References (72)

1. Akbarian, S., Kim, J.J., Potkin, S.G., Hagman, J.O., Tafazzoli, A., Bunney, W.E. Jr & Jones, E.G. (1995) Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry, 52, 258-266.
2. Al-Amin, H.A., Weinberger, D.R. & Lipska, B.K. (2000) Exaggerated MK-801-induced motor hyperactivity in rats with the neonatal lesion of the ventral hippocampus. Behav. Pharmacol., 11, 269-278.
3. Alexander, M.J., Miller, M.A., Dorsa, D.M., Bullock, B.P., Melloni, R.H. Jr, Dobner, P.R. & Leeman, S.E. (1989) Distribution of neurotensin/neuromedin N mRNA in rat forebrain: unexpected abundance in hippocampus and subiculum. Proc. Natl Acad. Sci. USA, 86, 5202-5206.
4. Angulo, J.A., Coirini, H., Ledoux, M. & Schumacher, M. (1991) Regulation by dopaminergic neurotransmission of dopamine D2R mRNA and receptor levels in the striatum and nucleus accumbens of the rat. Brain Res. Mol. Brain Res., 11, 161-166.
5. Bauer, R., Mayr, A., Lederer, W., Needham, P.L., Kilpatrick, I.C., Fleischhacker, W.W. & Marksteiner, J. (2000) Further evidence that behavioral tests and neuropeptide mRNA and tissue level alterations can differentiate between typical and atypical antipsychotic drugs. Neuropsychopharmacology, 23, 46-55.
6. Bernard, V., Le Moine, C. & Bloch. B. (1991) Striatal neurons express increased level of dopamine D2 receptor mRNA in response to haloperidol treatment: a quantitative in situ hybridization study. Neuroscience, 45, 117-126.
7. Binder, E.B., Kinkead, B., Owens, M.J. & Nemeroff, C.B. (2001) The role of neurotensin in the pathophysiology of schizophrenia and the mechanism of action of antipsychotic drugs. Biol. Psychiatry, 50, 856-872.
8. Black, M.D., Lister, S., Hitchcock, J.M., Giersbergen, P. & Sorensen, S.M. (1998) Neonatal hippocampal lesion model of schizophrenia in rats: sex differences and persistence of effects into maturity. Drug Dev. Res., 4, 206-213.
9. Brake, W.G., Sullivan, R.M., Flores, G., Srivastava, L. & Gratton, A. (1999) Neonatal ventral hippocampal lesions attenuate the nucleus accumbens dopamine response to stress: an electrochemical study in the rat. Brain Res., 831, 25-32.
10. Buckland, P.R., O'Donovan, M.C. & McGuffin, P. (1992) Changes in dopamine D1, D2 and D3 receptor mRNA levels in rat brain following antipsychotic treatment. Psychopharmacology (Berl.), 106, 479-483.
11. Caboche, J., Vernier, P., Rogard, M., Julien, J.F., Mallet, J. & Besson, M.J. (1992) Role of dopaminergic D2 receptors in the regulation of glutamic acid decarboxylase messenger RNA in the striatum of the rat. Eur. J. Neurosci., 4, 438-447.
12. Carr, D.B. & Sesack, S.R. (1996) Hippocampal afferents to the rat prefrontal cortex: synaptic targets and relation to dopamine terminals. J. Comp. Neurol., 369, 1-15.
13. Casmer, S.A., Al-Tikriti, M.S., Baldwin, R.M., Seibyl, J.P., Innis, R.B. & Goldman-Rakic, P.S. (2000) Behavioral changes and [123I]IBZM equilibrium SPECT measurement of amphetamine-induced dopamine release in rhesus monkeys exposed to subchronic amphetamine. Neuropsychopharmacology, 22, 4-13.
14. Coirini, H., Schumacher, M., Angulo, J.A. & McEwen, B.S. (1990) Increase in striatal dopamine D2 receptor mRNA after lesions of haloperidol treatment. Eur. J. Pharmacol., 186, 369-371.
15. Costa, E., Davis, J., Grayson, D.R., Guidotti, A., Pappas, G.D. & Pesold, C. (2001) Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Neurobiol. Dis., 8, 723-742.
16. Creese, I., Sibley, D.R. & Xu, S.X. (1992) Expression of rat striatal D1 and D2 dopamine receptor mRNAs: ontogenetic and pharmacological studies. Neurochem. Int., 20 (Suppl.), 45S-48S.
17. Delfs, J.M., Ellison, G.D., Mercugliano, M. & Chesselet, M.F. (1995) Expression of glutamic acid decarboxylase mRNA in striatum and pallidum in an animal model of tardive dyskinesia. Exp. Neurol., 133, 175-188.
18. Egan, M.F., Hurd, Y., Hyde, T.M., Weinberger, D.R., Wyatt, R.J. & Kleinman, J.E. (1994) Alterations in mRNA levels of D2R receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias. Synapse, 18, 178-189.
19. Erlander, M.G., Tillakaratne, N.J., Feldblum, S., Patel, N. & Tobin, A.J. (1991) Two genes encode distinct glutamate decarboxylases. Neuron, 7, 91-100.
20. Flores, G., Barbeau, D., Quirion, R. & Srivastava, L.K. (1996) Decreased binding of dopamine D3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus. J. Neurosci., 16, 2020-2026.
21. Fox, C.A., Mansour, A. & Watson, S.J. Jr (1994) The effects of haloperidol on dopamine receptor gene expression. Exp. Neurol., 130, 288-303.
22. Goto, Y. & O'Donnell, P. (2002) Delayed mesolimbic system alteration in a developmental animal model of schizophrenia. J. Neurosci., 22, 9070-9077.
23. Grace, A.A. (1992) The depolarization block hypothesis of neuroleptic action: implications for the etiology and treatment of schizophrenia. J. Neural. Transm. Suppl., 36, 91-131.
24. Groenewegen, H.J., Vermeulen-Van Der Zee, E. & Te Kortschot, A. (1987) Organization of the projections from the subiculum to the ventral striatum in the rat. A study using anterograde transport of phaseolus vulgaris leucoagglutinin. Neuroscience, 23, 103-120.
25. Guidotti, A., Auta, J., Davis, J.M., Di-Giorgi-Gerevini, V., Dwivedi, Y., Grayson, D.R., Impagnatiello, F., Pandey, G., Pesold, C., Sharma, R., Uzunov, D., Costa, E. & DiGiorgi Gerevini, V. (2000) Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch. Gen. Psychiatry, 57, 1061-1069.
26. Heimer, L., Alheid, G. & Zaborsky, L. (1995) Basal ganglia. In Paxinos, G. (ed.), The Rat Nervous System. Academic Press, Inc., San Diego, pp. 579-628.
27. Heinz, A. (2002) Dopaminergic dysfunction in alcoholism and schizophrenia-psychopathological and behavioral correlates. Eur. J. Psychiatry, 17, 9-16.
28. Imperato, A., Obinu, M.C., Carta, G., Mascia, M.S., Casu, M.A. & Gessa, G.L. (1996) Reduction of dopamine release and synthesis by repeated amphetamine treatment: role in behavioral sensitization. Eur. J. Pharmacol., 317, 231-237.
29. Jay, T.M. & Witter, M.P. (1991) Distribution of hippocampal CA1 and subicular efferents in the prefrontal cortex of the rat studied by means of anterograde transport of Phaseolus vulgaris-leucoagglutinin. J. Comp. Neurol., 313, 574-586.
30. Jolkkonen, J., Jenner, P. & Marsden, C.D. (1994) GABAergic modulation of striatal peptide expression in rats and the alterations induced by dopamine antagonist treatment. Neurosci. Lett., 180, 273-276.
31. Kapur, S. & Remington, G. (2001) Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient. Biol. Psychiatry, 50, 873-883.
32. Kelley, A.E. & Domesick, V.B. (1982) The amygdalostriatal projection in the rat - an anatomical study by anterograde and retrograde tracing methods. Neuroscience, 7, 615-630.
33. Khan, Z.U., Koulen, P., Rubinstein, M., Grandy, D.K. & Goldman-Rakic, P.S. (2001) An astroglia-linked dopamine D2R-receptor action in prefrontal cortex. Proc. Natl Acad. Sci. USA, 98, 1964-1969.
34. Kinon, B.J. & Lieberman, J.A. (1996) Mechanisms of action of atypical antipsychotic drugs: a critical analysis. Psychopharmacology (Berl.), 124, 2-34.
35. Knable, M.B., Barci, B.M., Bartko, J.J., Webster, M.J. & Torrey, E.F. (2002) Molecular abnormalities in the major psychiatric illnesses: classification and recession tree (CRT) analysis of post-mortem prefrontal markers. Mol. Psychiatry, 7, 392-404.
36. Kuczenski, R., Segal, D.S. & Aizenstein, M.L. (1991) Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics. J. Neurosci., 11, 2703-2712.
37. Laprade, N. & Soghomonian, J.J. (1995) Differential regulation of mRNA levels encoding for the two isoforms of glutamate decarboxylase (GAD65 and GAD67) by dopamine receptors in the rat striatum. Brain Res. Mol. Brain Res., 34, 65-74.
38. Laruelle, M. & Abi-Dargham, A. (1999) Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies. J. Psychopharmacol., 13, 358-371.
39. Le Pen, G. & Moreau, J.L. (2002) Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol. Neuropsychopharmacology, 27, 1-11.
40. Levesque, D., Martres, M.P., Diaz, J., Griffon, N., Lammers, C.H., Sokoloff, P. & Schwartz, J.C. (1995) A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons. Proc. Natl Acad. Sci. USA, 92, 1719-1723.
41. Lillrank, S.M., Lipska, B.K., Kolachana, B. & Weinberger, D.R. (1999a) Altered levels of extracellular dopamine and 5-HIAA after restraint stress and amphetamine in rats with neonatal ventral hippocampal damage. An in vivo microdialysis study in awake rats. J. Neur. Transm., 106, 183-196.
42. Lillrank, S.M., Lipska, B.K., Weinberger, D.R., Fredholm, B.B., Fuxe, K. & Ferre, S. (1999b) Adenosine and dopamine receptor antagonist binding in the rat ventral and dorsal striatum: lack of changes after neonatal bilateral lesion of the ventral hippocampus. Neurochem. Int., 34, 235-244.
43. Lipska, B.K., Al-Amin, H.A. & Weinberger, D.R. (1998) Excitotoxic lesions of the rat medial prefrontal cortex: effects on abnormal behaviors associated with neonatal hippocampal damage. Neuropsychopharmacology, 19, 451-464.
44. Lipska, B.K., Chrapusta, S.J., Egan, M.F. & Weinberger, D.R. (1995) Neonatal excitotoxic ventral hippocampal damage alters dopamine response to mild chronic stress and haloperidol treatment. Synapse, 20, 125-130.
45. Lipska, B.K., Jaskiw, G.E. & Weinberger, D.R. (1993) Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology, 9, 67-75.
46. Lipska, B.K. & Weinberger, D.R. (1994) Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage. Neuropsychopharmacology, 10, 199-205.
47. Lipska, B.K. & Weinberger, D.R. (1997) Novel research strategies in the pharmacology of schizophrenia. Drugs Today, 33, 103-113.
48. Lipska, B.K. & Weinberger, D.R. (2000) To model a psychiatric disorder in animals: Schizophrenia as a reality test. Neuropsychopharmacology, 23, 223-239.
49. Matsunaga, T., Ohara, K., Natsukari, N. & Fujita, M. (1991) Dopamine D2-receptor mRNA level in rat striatum after chronic haloperidol treatment. Neurosci. Res., 12, 440-445.
50. Mavridis, M. & Besson, M.J. (1999) Dopamine - opiate interaction in the regulation of neostriatal and pallidal neuronal activity as assessed by opioid precursor peptides and glutamate decarboxylase messenger RNA expression. Neuroscience, 92, 945-966.
51. Mengod, G., Villaro, M.T., Landwehrmeyer, G.B., Martinez-Mir, M.I., Niznik, H.B., Sunahara, R.K., Seeman, P., O'Dowd, B.F., Probst, A. & Palacios, J.M. (1992) Visualization of dopamine D1, D2 and D3 receptor mRNAs in human and rat brain. Neurochem. Int., 20 (Suppl. 1), 33S-43S.
52. Merchant, K.M., Dobie, D.J., Filloux, F.M., Totzke, M., Aravagiri, M. & Dorsa, D.M. (1994) Effects of chronic haloperidol and clozapine treatment on neurotensin and c-fos mRNA in rat neostriatal subregions. J. Pharmacol. Exp. Ther., 271, 460-471.
53. Nylander, I. & Terenius, L. (1986) Chronic haloperidol and clozapine differentially affect dynorphin peptides and substance P in basal ganglia of the rat. Brain Res., 380, 34-41.
54. O'Donnell, P. & Grace, A.A. (1995) Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input. J. Neurosci., 15, 3622-3639.
55. O'Donnell, P., Lewis, B.L., Weinberger, D.R. & Lipska, B.K. (2002) Neonatal hippocampal damage alters electrophysiological properties of prefrontal cortical neurons. Cerebral Cortex, 12, 975-982.
56. Paxinos, G. & Watson, C. (1997) The Rat Brain in Stereotaxic Coordinates, compact 3rd edn. Academic Press, San Diego, CA.
57. Qin, Z.H., Zhang, S.P. & Weiss, B. (1994) Dopaminergic and glutamatergic blocking drugs differentially regulate glutamic acid decarboxylase mRNA in mouse brain. Brain Res. Mol. Brain Res., 21, 293-302.
58. Quirion, R., Gaudreau, P., Martel, J.C., St-Pierre, S. & Zamir, N. (1985) Possible interactions between dynorphin and dopaminergic systems in rat basal ganglia and substantia nigra. Brain Res., 331, 358-362.
59. Retaux, S., Trovero, F. & Besson, M.J. (1994) Role of dopamine in the plasticity of glutamic acid decarboxylase messenger RNA in the rat frontal cortex and the nucleus accumbens. Eur. J. Neurosci., 6, 1782-1791.
60. Sakai, K., Gao, X.M., Hashimoto, T. & Tamminga, C.A. (2001) Traditional and new antipsychotic drugs differentially alter neurotransmission markers in basal ganglia-thalamocortical neural pathways. Synapse, 39, 152-160.
61. Sams-Dodd, F., Lipska, B.K. & Weinberger, D.R. (1997) Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood. Psychopharmacology, 132, 303-310.
62. Sesack, S.R., Bressler, C.N. & Lewis, D.A. (1995) Ultrastructural associations between dopamine terminals and local circuit neurons in the monkey prefrontal cortex: a study of calretinin-immunoreactive cells. Neurosci. Lett., 200, 9-12.
63. Sesack, S.R. & Pickel, V.M. (1990) In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other. Brain Res., 527, 266-279.
64. Steiner, H. & Gerfen, C.R. (1998) Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp. Brain Res., 123, 60-76.
65. Swanson, L.W. & Cowan, W.M. (1975) A note on the connection and development of the nucleus accumbens. Brain Res., 92, 324-330.
66. van Tol, H.H., Riva, M., Civelli, O. & Creese, I. (1990) Lack of effect of chronic dopamine receptor blockade on D2R dopamine receptor mRNA level. Neurosci. Lett., 111, 303-308.
67. Volk, D.W., Austin, M.C., Pierri, J.N., Sampson, A.R. & Lewis, D.A. (2000) Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch. Gen. Psychiatry, 57, 237-245.
68. Wan, R.-Q., Giovanni, A., Kafka, S.H. & Corbett, R. (1996) Neonatal hippocampal lesions induced hyperresponsiveness to amphetamine: behavioral and in vivo microdialysis studies. Behav. Brain Res., 78, 211-223.
69. Wan, R.Q., Hartman, H. & Corbett, R. (1998) Alteration of dopamine metabolites in CSF and behavioral impairments induced by neonatal hippocampal lesions. Physiol. Behav., 65, 429-436.
70. Weinberger, D.R., Egan, M.F., Bertolino, A., Callicott, J.H., Mattay, V.S., Lipska, B.K., Berman, K.F. & Goldberg, T.E. (2001) Prefrontal neurons and the genetics of schizophrenia. Biol. Psychiatry, 50, 825-844.
71. Weinberger, D.R. & Lipska, B.K. (1995) Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: In search of common ground. Schiz. Res., 16, 87-110.
72. Yoshikawa, K., Williams, C. & Sabol, S.L. (1984) Rat brain preproenkephalin mRNA. cDNA cloning, primary structure, and distribution in the central nervous system. J. Biol. Chem., 259, 14301-14308.